These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4684553)

  • 1. The treatment of prostatic bone metastases with parathormone and radioactive phosphorus.
    Tong EC; Finkelstein P
    J Urol; 1973 Jan; 109(1):71-5. PubMed ID: 4684553
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate.
    Morales A; Burr RC; Bruce AW
    Can Med Assoc J; 1970 Aug; 103(4):372-3. PubMed ID: 5447717
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of metastatic carcinoma of the prostate to bone with parathormone and radioactive phosphorous.
    Merrin C; Bakshi S
    J Surg Oncol; 1974; 6(1):67-72. PubMed ID: 4132074
    [No Abstract]   [Full Text] [Related]  

  • 4. Parathormone and 32P therapy in prostatic cancer with bone metastases.
    Tong EC
    Radiology; 1971 Feb; 98(2):343-51. PubMed ID: 5099838
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of bone metastases with parathormone followed by radiophosphorus.
    Tong EC; Rubenfeld S
    Am J Roentgenol Radium Ther Nucl Med; 1967 Feb; 99(2):422-34. PubMed ID: 6020191
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Treatment of bone metastases from carcinoma of prostate with parathyroid hormone and radioactive phosphorus.
    Rubenfeld S
    Urology; 1973 Mar; 1(3):268-9. PubMed ID: 4802068
    [No Abstract]   [Full Text] [Related]  

  • 7. Parathormone-potentiated radiophosphorus therapy in prostatic carcinoma.
    Pinck BD; Alexander S
    Urology; 1973 Mar; 1(3):201-4. PubMed ID: 4802054
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone scan: in clinical perspective.
    Bisson J; Vickers M; Fagan WT
    J Urol; 1974 May; 111(5):665-9. PubMed ID: 4823975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation and development of the enzyme activity of phosphatases and the gammagraphic distribution of bone deposits in prostatic cancer (preliminary study)].
    Maganto Pavón E; Mateos Torres JA; Verdú Tartajo F; Boronat Tormo F; Mayayo Dehesa T; Romero Aguirre C
    Actas Urol Esp; 1981; 5(2):93-8. PubMed ID: 7270286
    [No Abstract]   [Full Text] [Related]  

  • 10. Phosphorus 32 for intractable pain in carcinoma of the prostate.
    Johnson DE; Haynie TP
    Tex Med; 1971 Mar; 67(3):57-9. PubMed ID: 4103609
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
    Cheung A; Driedger AA
    Radiology; 1980 Jan; 134(1):209-12. PubMed ID: 6153129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorus-32 for intractable pain in carcinoma of prostate. Analysis of androgen priming, parathormone rebound, and combination therapy.
    Johnson DE; Haynie TP
    Urology; 1977 Feb; 9(2):137-9. PubMed ID: 65816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteolytic metastases in cancer of the prostate].
    Cayla J; Rondier J; Jabre E; de Saint-Maur P; Couturaud M
    Ann Med Interne (Paris); 1972 Apr; 123(4):307-22. PubMed ID: 5077034
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
    Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit.
    Kida T; Higuchi Y
    Oncology; 1983; 40(5):346-50. PubMed ID: 6621997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioactive phosphorus in the treatment of metastasis to bone from carcinoma of the prostate.
    Morin LJ; Stevens JC
    J Urol; 1967 Jan; 97(1):130-2. PubMed ID: 4163114
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful relief of severe pain from bone metastases of carcinoma of the prostate by the treatment with P32].
    Nakaarai K; Tokizane M; Okuda N; Ito S
    Hinyokika Kiyo; 1966 Dec; 12(12):1429-34. PubMed ID: 4167082
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone scanning and plasma phosphatases in carcinoma of the prostate.
    O'Donoghue EP; Constable AR; Sherwood T; Stevenson JJ; Chisholm GD
    Br J Urol; 1978 May; 50(3):172-7. PubMed ID: 753455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of 89strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report.
    Firusian N; Mellin P; Schmidt CG
    J Urol; 1976 Dec; 116(6):764-8. PubMed ID: 1003647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES.
    SCHIRMER HK; RICHARDS GJ
    J Urol; 1964 Dec; 92():714-20. PubMed ID: 14241206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.